← FTC press releases
FTC Requires Sale of Generic Cancer Pain Drug and Muscle Relaxant as Conditions of Tevas $6.8 Billion Acquisition of Cephalon
other
· 2011-10-01 ·
$6.80B
Source
Authoritative
FTC press release
Machine
JSON-LD
·
Markdown